Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resdevco is an Israeli pharmaceutical research and development company founded by Professor Shabtay Dikstein of the Hebrew University of Jerusalem. The company specializes in the development of innovative topical formulations for ophthalmology and dermatology, with a particular focus on treating dry eye syndrome and corneal disorders. Resdevco is best known for its proprietary electrolyte-based eye drops and moisture-retaining skin care products that utilize Professor Dikstein's research into osmotic balance and cell protection. The company operates primarily through licensing its patented technologies to global pharmaceutical partners for manufacturing and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Professor Shabtay Dikstein.